ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint744,947 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentZugAphaia Pharma AG
Aphaia Pharma AG Logo
Verified· 2 sources

Aphaia Pharma AG

Summary

About the company

The core activity of Aphaia Pharma AG is the development and marketing of pharmaceuticals, particularly in the fields of life sciences and biotechnology. The company focuses on the research and development of innovative therapeutics and medications, particularly in the areas of microvascular medicine and the treatment of diseases such as obesity and metabolic disorders.

AI-generated
Offering

Products & services

Industry:Research & Development
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Pharmaceutical Industry
✓ Offered4
Oral glucose formulation (APH-012 / APHD-012)
Oral, coated glucose formulation for targeted release in the small intestine; for the treatment of obesity, prediabetes and other metabolic disorders, currently being evaluated in Phase 2 studies.
Development of precision-driven drug formulations
Development of proprietary, precision-targeted drug formulations with coated beads for the targeted delivery of natural substances to defined segments of the gastrointestinal tract.
Clinical development in obesity
Phase 2 studies in obesity with a placebo-controlled proof-of-concept design; investigation of weight change and other parameters of metabolic diseases.
Clinical development for prediabetes prevention
Phase 2 study in prediabetes to improve glucose tolerance and to assess the potential to prevent type 2 diabetes.
Comparisons

Aphaia Pharma AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Aphaia Pharma AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Aphaia Pharma AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Bahnhofstrasse 28
6300 Zug

At a glance

Legal form
Corporation
UID
CHE-301.157.491
Founded
2018 · 8 years
Last commercial register change
December 30, 2025
Employees
21 to 50

Knowledge

No knowledge articles yet

Once Aphaia Pharma AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

GS
G&L Scientific (Schweiz) GmbH
Zug
NT
Nektar Therapeutics Europe GmbH
Zug
NC
Novotech Clinical Research AG
Zug
AI
Apellis International GmbH
Zug
PR
Premier Research Group SA
Zug
AS
Alnylam Switzerland GmbH
Zug
CP
Crinetics Pharmaceuticals Europe GmbH
Zug
JP
Jazz Pharmaceuticals Switzerland GmbH
Zug